09/24/2025
Please join us for our webinar where we will explore the latest advancements in ovarian cancer care and strategies for streamlining genetic and genomic testing for patients.
09/30/2025
The third session of our quarterly Molecular Tumor Board, in partnership with Clarified Health, focused on breast cancer, providing comprehensive insights from tumor genomic profiling and germline results. We will discuss critical biomarker results necessary for an informed discussion guiding treatment decisions.
11/11/2025
Join us for a practical, expert-led session focused on the first two stages of a successful program: Screen and Evaluate. Learn how to identify patients at elevated cancer risk and assess them using evidence-based tools.
Elevating High-Risk Breast Cancer Care: The Impact of MyRisk® Hereditary Cancer Test with RiskScore®
Date:
10/30/2025
Time:
7:00 PM EST
Duration:
1 hour
Speakers:
CEU:
No
Beyond Diagnosis: Transforming Care with Genetic Insights
11/06/2025
Cancer Risk Assessment Program Workshop Part 1
12-1 PM EST
Genetics & Family Ties: The Power of Testing for Lynch Syndrome
11/18/2025
6-7 PM MT
Cancer Risk Assessment Program Workshop – Part 2
11/19/2025
12-1 PM PST
Navigating hereditary cancer guidelines for emerging genes
10/21/2025
Yes
Turning Insights into Impact: A Guide to Breast Cancer Risk Assessment
10/16/2025
Quarterly Molecular Tumor Board: Review targeted therapies and management options for breast cancer patients
Combining genetic and genomic testing in ovarian cancer through multidisciplinary collaboration
Guiding Golden Years: How Providers use the GeneSight test to Illuminate and Improve Treatment Outcomes in Patients 65+
08/05/2025
Breaking Barriers Together: Creative Approaches to Genetic Services in Oncology
07/30/2025
Quarterly Molecular Tumor Board: Review targeted therapies and management options for gynecologic cancer patients.
07/22/2025
Big Data, Little Data: Utilizing research registries to foster collaboration in cancer genetics and impact patient care
05/20/2025
Explore targeted therapies and management options for gastrointestinal cancer patients based on germline and genomic findings.
05/15/2025
The GeneSight Advantage: Leading the Way in Mental Health PGx
04/29/2025
Maternal Malignancy Detection Through pcfDNA Screening
04/23/2025
Enhancing Variant Interpretation Through RNA Analysis
10/23/2024
From Genes to Treatment: Real-World Evidence with GeneSight Case Studies
10/15/2024
Guidelines and Clinical Applications of Germline and Somatic Variant Classification
10/08/2024
Continue Going Beyond Green, Yellow, Red on the GeneSight® Report
06/11/2024
Part 3 - Hot Topics in Breast Cancer Genetic Testing
05/22/2024
Integrating genetic insights to guide personalized surgical decision making and high-risk management
04/12/2024
APC: The Tour of Time
03/27/2024
Going Beyond Green, Yellow, Red on the GeneSight® Report
03/19/2024
Updates to Cancer Risk and Clinical Guidance for Germline Variation in CHEK2
02/27/2024
Part 2 - Breast Cancer Risk Assessment and High-Risk Management
02/15/2024
Part 1 - Foundations and Application of Germline Testing
11/30/2023